XML 19 R5.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid In Capital
Accumulated Deficit
Balance at the beginning (in shares) at Dec. 31, 2024 9,608,914      
Balance at the beginning at Dec. 31, 2024 $ 72,546      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Issuance of Series C-2 redeemable convertible preferred stock, net of issuance costs and tranche liability (in shares) 4,933,589      
Issuance of Series C-2 redeemable convertible preferred stock, net of issuance costs and tranche liability $ 54,939      
Balance at the end (in shares) at Mar. 31, 2025 14,542,503      
Balance at the end at Mar. 31, 2025 $ 127,485      
Beginning balance (in shares) at Dec. 31, 2024   2,196,423    
Beginning balance at Dec. 31, 2024 (60,474) $ 0 $ 4,387 $ (64,861)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock option exercises (in shares)   86,579    
Stock option exercises 100   100  
Stock-based compensation 345   345  
Net loss (8,823)     (8,823)
Comprehensive loss (8,823)     (8,823)
Ending balance (in shares) at Mar. 31, 2025   2,283,002    
Ending balance at Mar. 31, 2025 $ (68,852) $ 0 4,832 (73,684)
Balance at the beginning (in shares) at Dec. 31, 2025 20,341,968      
Balance at the beginning at Dec. 31, 2025 $ 204,537      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Conversion of redeemable convertible preferred stock into common stock on the initial public offering (in shares) (20,341,968)      
Conversion of redeemable convertible preferred stock into common stock on the initial public offering $ (204,537)      
Balance at the end (in shares) at Mar. 31, 2026 0      
Balance at the end at Mar. 31, 2026 $ 0      
Beginning balance (in shares) at Dec. 31, 2025 2,203,620 2,203,620    
Beginning balance at Dec. 31, 2025 $ (98,837) $ 0 5,893 (104,730)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock option exercises (in shares) 105,717 105,717    
Stock option exercises $ 55   55  
Stock-based compensation 1,675   1,675  
Conversion of redeemable convertible preferred stock into common stock on the initial public offering (in shares)   20,341,968    
Conversion of redeemable convertible preferred stock into common stock on the initial public offering 204,537   204,537  
Issuance of common stock in initial public offering, net of underwriting discounts and commissions and offering costs (in shares)   10,781,250    
Issuance of common stock in initial public offering, net of underwriting discounts and commissions and offering costs 156,500   156,500  
Net loss (13,818)     (13,818)
Comprehensive loss $ (13,818)     (13,818)
Ending balance (in shares) at Mar. 31, 2026 33,432,555 33,432,555    
Ending balance at Mar. 31, 2026 $ 250,112 $ 0 $ 368,660 $ (118,548)